Phreesia, Inc. (NYSE:PHR) Short Interest Update

Phreesia, Inc. (NYSE:PHR) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 2,730,000 shares, a drop of 14.7% from the November 30th total of 3,200,000 shares. Based on an average daily trading volume, of 406,000 shares, the short-interest ratio is presently 6.7 days.

Phreesia Stock Performance

NYSE PHR opened at $25.76 on Monday. The firm’s fifty day moving average is $21.30 and its two-hundred day moving average is $22.19. Phreesia has a one year low of $17.07 and a one year high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74. The firm has a market cap of $1.50 billion, a PE ratio of -17.52 and a beta of 0.98.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter in the previous year, the firm posted ($0.58) EPS. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. Analysts expect that Phreesia will post -1.16 earnings per share for the current year.

Analyst Ratings Changes

PHR has been the subject of several research analyst reports. Robert W. Baird lowered their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Needham & Company LLC restated a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Tuesday, December 10th. JMP Securities reiterated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Truist Financial raised their price objective on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $23.00 target price on shares of Phreesia in a research note on Friday, September 27th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, Phreesia currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.33.

Insider Transactions at Phreesia

In other Phreesia news, insider Yvonne Hui sold 2,791 shares of Phreesia stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $20.92, for a total transaction of $58,387.72. Following the completion of the sale, the insider now directly owns 27,228 shares in the company, valued at $569,609.76. This trade represents a 9.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total transaction of $25,488.36. Following the completion of the transaction, the general counsel now owns 119,791 shares in the company, valued at approximately $2,519,204.73. This represents a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 90,342 shares of company stock worth $2,041,225 in the last 90 days. Insiders own 5.80% of the company’s stock.

Institutional Investors Weigh In On Phreesia

Hedge funds have recently modified their holdings of the stock. International Assets Investment Management LLC raised its position in Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares during the last quarter. nVerses Capital LLC increased its stake in shares of Phreesia by 76.5% during the second quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after acquiring an additional 1,300 shares during the period. Lombard Odier Asset Management USA Corp purchased a new position in Phreesia during the second quarter worth about $202,000. Point72 DIFC Ltd purchased a new stake in Phreesia in the 2nd quarter valued at approximately $209,000. Finally, XTX Topco Ltd purchased a new stake in Phreesia in the 3rd quarter valued at approximately $247,000. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.